open access to scientific and medical research

Back to Journals » ClinicoEconomics and Outcomes Research » Volume 7

Original Research

Noteworthy comment: The results of this research led to recommendations for improvement and the potential extrapolation of these best practices to other HTA organizations worldwide, along with suggestions for pan-Canadian Oncology Drug Review (pCODR’s) continued evolution in conjunction with its integration into Canadian Agency for Drugs and Technologies in Health (CADTH). It is clear that the transition of pCODR to CADTH provides an opportunity for these newly-amalgamated HTA agencies in Canada

Highly-accessed

Evolution of health technology assessment: best practices of the pan-Canadian Oncology Drug Review

Total article views		HTML views	PDF downloads	Totals
20,464	Dovepress*	18,540+	2,202	20,742
	PubMed Central*	1,924	601	2,525
	Totals	20,464	2,803	23,267
*Since 3 June 2015 +Since July 2016

Total mentioned	Facebook	Delicious	Reddit	Twitter	Others
32	1	0	0	14	17

View citations on PubMed Central and Google Scholar